Attitude towards medication deprescribing among older patients attending the geriatric centre: a cross-sectional survey in Southwest Nigeria DOI Creative Commons
Wuraola Akande‐Sholabi,

Comfort Oluwatobi Ajilore,

Lawrence A. Adebusoye

и другие.

BMJ Open, Год журнала: 2023, Номер 13(11), С. e078391 - e078391

Опубликована: Ноя. 1, 2023

Objectives This study set out to assess older people’s perception of their medications, attitude towards medication use and willingness have medications deprescribed in a geriatric centre Southwestern Nigeria. Design setting A cross-sectional was conducted at the Chief Tony Anenih Geriatric Centre, University Ibadan, using an interviewer-administered questionnaire. The questionnaire used revised version Patient’s Attitude Towards Deprescribing Questionnaire. Descriptive statistics, multivariate bivariate analyses were performed SPSS V.23. Statistical significance p<0.05. Participants 415 patients aged ≥60 years who attended College Hospital Ibadan between April July 2022. Main outcome measure primary person deprescribe if recommended by physician. Results mean age participants 69.6±6.4 years, 252 (60.7%) female. Overall, positive deprescribing among respondents 60.5% 89.7%, respectively. Factors significantly associated with financial self-support (p=0.021), having no previous hospital admission (p=0.009), better-perceived quality health relative peers (p<0.0001), polypharmacy (p=0.003), domains burden (p=0.007), appropriateness concerns about stopping (p<0.0001) involvement (p<0.0001). predictive factors for improved direct (OR=2.463; 95% CI 1.501 4.043, p<0.0001), (OR=0.462; 0.254 0.838, p=0.011) (OR=2.031; 1.191 3.463, p=0.009). Conclusion demonstrated greater physicians it. Predictive that may influence medications.

Язык: Английский

Latent class analysis identifies four distinct Patient Deprescribing Typologies among older adults in four countries DOI Creative Commons
Kristie Rebecca Weir, Vincent D. Marshall, Sarah E. Vordenberg

и другие.

Innovation in Aging, Год журнала: 2025, Номер 9(2)

Опубликована: Янв. 1, 2025

Polypharmacy, the concurrent use of multiple medicines, is a growing concern among older adults and those with chronic conditions. Deprescribing through dose reduction or discontinuing selected medicines strategy for reducing medicine-related harm. The Patient Typology was developed using qualitative methods to describe varying factors that are important when they consider deprescribing. objective this study quantitative define distinct classes via Typology. This used cross-sectional experimental design in which data collected an online survey from participants 65 years Australia, Netherlands, United Kingdom, States. A latent class analysis performed 4-item about beliefs importance how learn medicine decision-making preferences, attitudes towards stopping medicines. Older (n = 2,250) were median 70 2-thirds reported their highest level education associate's degree trade school less. We identified 4 classes: Class 1 "Trusts doctor" (41.6%), 2 "Makes own decisions" (30.2%), 3 "Avoids deprescribing" (15.5%), 'Medicines not important' (12.7%). report diverse perspectives deprescribing, emphasizing need tailored communication strategies clinical settings. Additional research needed examine adults' preferences real-world contexts refine improve deprescribing interventions. NCT04676282.

Язык: Английский

Процитировано

2

Older Adults’ Attitudes Toward Deprescribing in 14 Countries DOI Creative Commons
Renata Vidonscky Lüthold, Katharina Tabea Jungo, Kristie Rebecca Weir

и другие.

JAMA Network Open, Год журнала: 2025, Номер 8(2), С. e2457498 - e2457498

Опубликована: Фев. 10, 2025

Importance Better understanding of patients’ attitudes toward deprescribing specific medications will inform future interventions. Objective To investigate older adults’ by investigating which they would like to have deprescribed, the reasons why, and patient factors associated with interest in deprescribing. Design, Setting, Participants This survey study was conducted from May 2022 December 2023 primary care settings 14 countries. Patients aged 65 years or taking 5 more were consecutively recruited their general practitioner (GP) completed questionnaire. Exposures Patient characteristics, including gender, number medications, GP education level, financial status, confidence completing medical forms, self-rated health, satisfaction trust GP, country. Main Outcomes Measures The outcomes as measured responses question, “Thinking about your current medication list, are there any that you stop reduce dose of?” Multilevel multivariable logistic regression analysis used, adjusted for clustering effect at country association between characteristics Results Of 1340 patients (mean [SD], 96 [47] per country), 736 (55%) women, 580 (44%) had secondary school highest level education, 1089 (82%) satisfied 589 expressed deprescribe 1 medications. varying levels, 79% (86 109 patients) Poland 23% (21 Bulgaria. 3 most reported deprescribed diuretics (111 1002 [11%]), lipid-modifying agents (109 acting on renin-angiotensin system (83 [8%]). odds naming least lower higher (odds ratio, 0.31; 95% CI, 0.21-0.47) 0.960; 0.930-0.998). Conclusions Relevance In this older, varied across countries, demonstrating interventions could be impactful when adapted contexts. These findings highlight importance patient-practitioner communication ensuring appropriate use.

Язык: Английский

Процитировано

1

Older adults’ attitudes towards deprescribing and medication changes: a longitudinal sub-study of a cluster randomised controlled trial DOI Creative Commons
Katharina Tabea Jungo, Kristie Rebecca Weir, Damien Cateau

и другие.

BMJ Open, Год журнала: 2024, Номер 14(1), С. e075325 - e075325

Опубликована: Янв. 1, 2024

Objective To investigate the association between older patients’ willingness to have one or more medications deprescribed and: (1) change in medications, (2) appropriateness of and (3) implementation prescribing recommendations generated by electronic decision support system tested ‘Optimising PharmacoTherapy In Multimorbid Elderly Primary CAre’ (OPTICA) trial. Design A longitudinal sub-study OPTICA trial, a cluster randomised controlled Setting Swiss primary care settings. Participants were aged ≥65 years, with ≥3 chronic conditions ≥5 regular recruited from 43 general practitioner (GP) practices. Exposures Patients’ was assessed using three questions ‘revised Patient Attitudes Towards Deprescribing’ (rPATD) questionnaire its concerns about stopping score. Measures/analyses Medication-related outcomes collected at 1 year follow-up. Aim outcome: number long-term baseline 12 month 2 medication (Medication Appropriateness Index). 3 binary variable on whether any recommendation during review implemented. We used multilevel linear regression analyses (aim aim 2) logistic 3). Models adjusted for sociodemographic variables clustering effect GP level. Results 298 patients completed rPATD, 45% women 78 years median age. statistically significant found score over time (per 1-unit increase average use 0.65 higher; 95% CI: 0.08 1.22). Other than that we did not find evidence associations agreement deprescribing medication-related outcomes. Conclusions an most measures patient year. Trial registration NCT03724539 .

Язык: Английский

Процитировано

6

The Patient Typology about deprescribing and medication‐related decisions: A quantitative exploration DOI Creative Commons
Kristie Rebecca Weir, Aaron M. Scherer, Sarah E. Vordenberg

и другие.

Basic & Clinical Pharmacology & Toxicology, Год журнала: 2023, Номер 134(1), С. 39 - 50

Опубликована: Июнь 10, 2023

Abstract This study aimed to test the adequacy of a quantitative measure our qualitatively developed Patient Typology—categories older adults' attitudes towards medicines and medicine decision‐making—and identify characteristics associated with each Typology. We conducted secondary data analyses subset survey item measures adults (≥65 years) who were members online panels in Australia, United Kingdom, States Netherlands ( n = 4688). Multinomial logistic regression assessed associations between demographic, psychosocial medication‐related measures. Mean age was 71.5 (5), 47.5% participants female. Factors an increased likelihood identifying Typology 1 ‘Attached medicines’ over 2 ‘Open deprescribing’ higher positive attitude polypharmacy (RRR 1.12, p <0.001) need for certainty 1.11, 0.039). 3 ‘Defers (medication decision‐making) others’ 1.47 per 10‐year increase, decreased prior deprescribing experience 0.73, 0.033). provides validation large samples from four countries, quantitatively‐measured typologies generally aligning derived categories. Our succinct way researchers can assess deprescribing.

Язык: Английский

Процитировано

6

Exploring GP and patient attitudes towards the use and deprescribing of dietary supplements: a survey study in Switzerland DOI Creative Commons
Renata Vidonscky Lüthold,

Zsofia Rozsnyai,

Kristie Rebecca Weir

и другие.

BMC Primary Care, Год журнала: 2024, Номер 25(1)

Опубликована: Окт. 3, 2024

Язык: Английский

Процитировано

0

Attitude towards medication deprescribing among older patients attending the geriatric centre: a cross-sectional survey in Southwest Nigeria DOI Creative Commons
Wuraola Akande‐Sholabi,

Comfort Oluwatobi Ajilore,

Lawrence A. Adebusoye

и другие.

BMJ Open, Год журнала: 2023, Номер 13(11), С. e078391 - e078391

Опубликована: Ноя. 1, 2023

Objectives This study set out to assess older people’s perception of their medications, attitude towards medication use and willingness have medications deprescribed in a geriatric centre Southwestern Nigeria. Design setting A cross-sectional was conducted at the Chief Tony Anenih Geriatric Centre, University Ibadan, using an interviewer-administered questionnaire. The questionnaire used revised version Patient’s Attitude Towards Deprescribing Questionnaire. Descriptive statistics, multivariate bivariate analyses were performed SPSS V.23. Statistical significance p<0.05. Participants 415 patients aged ≥60 years who attended College Hospital Ibadan between April July 2022. Main outcome measure primary person deprescribe if recommended by physician. Results mean age participants 69.6±6.4 years, 252 (60.7%) female. Overall, positive deprescribing among respondents 60.5% 89.7%, respectively. Factors significantly associated with financial self-support (p=0.021), having no previous hospital admission (p=0.009), better-perceived quality health relative peers (p<0.0001), polypharmacy (p=0.003), domains burden (p=0.007), appropriateness concerns about stopping (p<0.0001) involvement (p<0.0001). predictive factors for improved direct (OR=2.463; 95% CI 1.501 4.043, p<0.0001), (OR=0.462; 0.254 0.838, p=0.011) (OR=2.031; 1.191 3.463, p=0.009). Conclusion demonstrated greater physicians it. Predictive that may influence medications.

Язык: Английский

Процитировано

0